Israel is home to more than 750 medical device companies, 300 pharmaceutical/biotech companies, and 170 other life science or healthcare IT companies. David Dykeman, co-chair of Greenberg Traurig’s Life Science & Medical Technology Group, describes Israel as a “biomedical and healthcare powerhouse.”
David recently led a delegation of New England executives and investors from the biomedical, healthcare and life science sectors to spend three days exploring Israeli innovation and commercialization, learning about Israel’s cutting edge medical technology and investment trends, and speaking with executives of Israeli companies. In return, Israeli executives learned more about why Boston – with its own tech innovation, renowned universities and venture capital investors – is a natural fit for Israeli companies looking to enter the U.S. market.
The itinerary included meetings with medical device and healthcare industry leadership, medical technology entrepreneurs, and policy makers, as well as private meetings with the leadership of several leading Israeli companies. Greenberg Traurig also hosted a dinner reception with leaders in the Israeli life sciences industry.
The trip, organized by the New England-Israel Business Council and Combined Jewish Philanthropies, was modeled after former Massachusetts Gov. Deval Patrick’s trade mission to Israel in May 2014. For more information about the trip, see the firm’s press release.